Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

SELL
$98.98 - $115.74 $9,700 - $11,342
-98 Reduced 0.54%
18,149 $2.1 Million
Q2 2023

Aug 04, 2023

BUY
$96.34 - $112.38 $205,493 - $239,706
2,133 Added 13.24%
18,247 $1.88 Million
Q3 2022

Oct 19, 2022

BUY
$58.92 - $84.67 $137,401 - $197,450
2,332 Added 16.92%
16,114 $997,000
Q2 2022

Jul 13, 2022

BUY
$79.4 - $116.36 $30,569 - $44,798
385 Added 2.87%
13,782 $1.1 Million
Q1 2022

Apr 19, 2022

SELL
$86.42 - $109.81 $4,753 - $6,039
-55 Reduced 0.41%
13,397 $1.41 Million
Q4 2021

Jan 20, 2022

BUY
$98.56 - $119.91 $17,050 - $20,744
173 Added 1.3%
13,452 $1.45 Million
Q3 2021

Oct 15, 2021

SELL
$91.91 - $110.37 $8,271 - $9,933
-90 Reduced 0.67%
13,279 $1.45 Million
Q2 2021

Jul 19, 2021

BUY
$86.24 - $95.92 $79,340 - $88,246
920 Added 7.39%
13,369 $1.25 Million
Q1 2021

May 07, 2021

BUY
$71.83 - $95.48 $8,116 - $10,789
113 Added 0.92%
12,449 $1.15 Million
Q4 2020

Feb 02, 2021

BUY
$67.0 - $84.39 $826,512 - $1.04 Million
12,336 New
12,336 $902,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.